Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Prevention of colorectal cancer through multiomics blood testing: The PREEMPT CRC study.
Authors
Girish Putcha
Freenome Holdings, Inc., South San Francisco, CA
Girish Putcha , Chuanbo Xu , Aasma Shaukat, MD, MPH , Theodore R. Levin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
Clinical Trial Registration Number
NCT04369053
DOI
10.1200/JCO.2022.40.4_suppl.TPS208
Abstract #
TPS208
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinical performance of a multimodal screening blood test for advanced adenomas and CRC in an average-risk cohort of 1,038 participants.
First Author: Shai Friedland
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Use of glycoproteome profiles to detect advanced adenomas and colorectal cancer.
First Author: Khushbu Desai
Poster
2022 ASCO Annual Meeting
Comparison of simulated outcomes between stool- and blood-based colorectal cancer screening tests.
First Author: A. Fendrick
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Preferences for colorectal cancer screening of physicians and individuals at average risk in the United States: A discrete choice experiment.
First Author: Sebastian Heidenreich